Orthofix
Empowering Bone Healing with Best-in-Class Regeneration Solutions

In musculoskeletal medicine, recovery is often the true test of innovation. Healing in spinal fusion or nonunion fracture demands more than just surgical precision—it calls for comprehensive postoperative support.

Orthofix is redefining postoperative care with advanced bone growth therapy devices built with surgeons and patients in mind. By blending clinical efficacy with ease of use, the company provides a safe, effective, and non-surgical alternative to overcome bone healing challenges.

A customer-first mantra drives every aspect of its operations, from product development to post-delivery care. This approach recognizes the distinct and interconnected needs of both patients and surgeons or prescribing physicians.

“We take a white-glove approach to both surgeon and patient satisfaction, and that’s our biggest competitive advantage,” said Jason Shallenberger, president of Orthofix Bone Growth Therapies, who recently celebrated his 20th anniversary with the company.

Orthofix’s products focus on two therapeutic modalities in bone growth: spinal fusion and fracture healing. Backed by innovation, its comprehensive clinical portfolio of bone growth therapy stimulators promotes the healing process by delivering pulses of electromagnetic energy to the fusion or injury site, or by stimulating the bone's natural healing process through the use of ultrasound waves.

A Holistic Approach to Optimal Recovery

Bone healing is a complex biological process influenced by numerous variables. Surgeons closely evaluate the clinical efficacy of any product or device before integrating it into their practice. Orthofix’s bone growth therapy devices are FDA-approved and backed by robust clinical evidence. “Orthofix has the most robust clinical portfolio in the bone growth stimulation space,” said Shallenberger. This scientific rigor gives surgeons confidence in prescribing these devices for improved patient outcomes.

Beyond clinical performance, the devices are distinguished by their intuitive design. To guarantee a smooth user experience and encourage consistent use of devices, every product is carefully crafted with patient usability in mind.

By placing human interaction at the core of its business model, Orthofix ensures a customer service experience as exceptional as its products. Its field representatives are not just salespeople; they are specialists in bone growth therapy, equipped with extensive knowledge through rigorous training and continuous education. Their expertise enables effective customer engagement, fostering trust and long-term relationships.

Once an Orthofix device is prescribed, the representatives contact the patient’s insurance provider to verify benefits and secure prior authorization. They then schedule a meeting with the patient at the doctor's office or their home. The representative delivers the device and provides clear instructions on how to use it. This hands-on education encourages user compliance and ultimately contributes to optimal recovery.

Targeted Therapies for Complex Conditions

Patient comorbidities like diabetes, high BMI or a history of tobacco use can impair the natural healing process of the bones and delay osteogenesis. Orthofix’s lumbar and cervical stimulators, SpinalStim and CervicalStim, are prescribed as an adjunct to surgery for such high-risk patients.

Patients often develop lumbar pseudoarthrosis post-surgery. Orthofix’s SpinalStim is the only FDA-approved device on the market for both a lumbar spinal fusion adjunct and as a non-surgical treatment for spinal pseudoarthrosis. Similarly, CervicalStim is the only device approved by the FDA and trusted by surgeons for treating cervical non-fusions.

For fracture care and management, Orthofix offers two primary products: PhysioStim and AccelStim.

The PhysioStim device is prescribed to treat nonunion fractures that show no signs of healing within 90 days. The device delivers low-level pulsed electromagnetic field (PEMF) treatment around the nonunion fracture site, providing 360 degrees of penetration to effectively target the injury.

The AccelStim device is the surgeon’s go-to choice for improving the healing of nonunion and fresh fractures. The device stimulates the bone’s natural healing process by delivering low-intensity pulses of ultrasound waves to the fracture site. It is an FDA-approved device for immediate post-injury use without the usual 90-day waiting period for nonunion diagnosis.

Orthofix’s devices are augmented by the STIM onTrack app, which enhances recovery with digital intelligence. Winner of global and national awards, the Bluetooth-enabled platform seamlessly connects to its bone growth therapy devices, allowing patients to track device usage, log treatment sessions and manage their recovery timeline, all in one place. It also provides surgeons with visibility into patient compliance. The company continues to introduce advanced app features like live support and patient-reported outcomes tracking, refining the recovery experience with every update.

Bone Healing in Action

Orthofix’s real-world impact is profound, and in numerous cases, it has proven to be a game changer for patients. In one instance, a patient suffered a traumatic tibia fracture while traveling out of state and underwent extensive surgery. After 6 months of recovery, the surgeon referred the patient to a physician in his home state for follow-up care. Despite the complex procedure, his recovery showed no signs of bone-healing progress.

When faced with the possibility of a second surgery—involving six more months of recovery, physical pain, emotional strain and added costs—his physician suggested Orthofix’s PhysioStim bone growth stimulator as an alternative.

After reviewing the device's safety and clinical backing, the patient agreed to try it. The therapy successfully stimulated bone growth, leading to full recovery without further surgical intervention.

“These are the types of stories which inspire us knowing we were able to provide a solution to aid in someone’s recovery without surgical intervention,” said Shallenberger.

Executing with Precision, Expanding with Purpose

Orthofix’s sales strategy is a key part of its success. Rather than relying on broad distributor networks that handle multiple product lines, it takes a focused, market-by-market approach. This ensures resources are deployed based on the distinct needs of each region. Many distributors juggle multiple devices across various specialties, but Orthofix’s direct reps and a majority of its distribution partners only sell bone growth stimulation devices.

“When surgeons think of Orthofix, they think of bone healing because that’s what we do. Our reps focus exclusively on spine or fracture care, which empowers them to understand the clinical challenges in depth and deliver solutions with confidence,” said Shallenberger.

This high level of field knowledge directly supports Orthofix’s broader mission of advancing bone healing through precision and performance. Building on this foundation, the company is expanding its impact across clinical, product and geographic lines.

Clinically, Orthofix continues to invest in research to strengthen and expand its device indications. The success of CervicalStim is a direct result of that commitment to evidence-based development. The same mindset is now shaping innovation across other therapeutic areas. At every step, the focus remains on the end user, designing devices that are more comfortable, easier to use and better aligned with patient and provider needs.

As the demand for smarter, safer postoperative solutions grows, Orthofix continues to lead with purpose. Through its best-in-class bone growth therapy devices and customer support, the company is helping people heal and live active and fulfilling lives.